Skip to main content
. Author manuscript; available in PMC: 2013 Aug 19.
Published in final edited form as: Diabetes. 2007 Apr;56(4):960–967. doi: 10.2337/db06-1254

TABLE 1.

Number of animals (eyes) examined in the various models

Route of
administration
Intravitreous * Systemic
Model Total animals Flatmount Cryosection Flatmount Cryosection
OIR 8 8 (16) ND ND ND
I/R 20§ 6 (6) 4 (4) 6 (12) 4 (8)
STZ-induced diabetic mice 12§ 4 (4) 2 (2) 4 (8) 2 (4)
Normal control mice 12§ 4 (4) 2 (2) 4 (8) 2 (4)
BBZDR/Wor diabetic rats 12§ 12 (12) ND ND ND
BBZDR/Wor control rats 12§ 12 (12) ND ND ND
*

One eye from each animal received cells by intravitreous injection.

Both eyes from each animal were included for analysis.

One eye from each animal was injured and given cells by intravitreous injection; the contralateral eye was used as unaffected control.

§

Animals were divided equally to receive huEPCs of either nondiabetic or diabetic origin. ND, not done.

HHS Vulnerability Disclosure